Pfizer Corporation

Other

Agriculture Victoria Services Pty Limited

Pfizer Products Inc.

Zoetis LLC

Pig Research and Development Corporation

Austrailian Pork Limited

Everett Lee Rosey

Frederick H Weber

Tonia Sue Agin

Robert Gerard Ankenbauer

Brian T Suiter

Manuel Campos

Kendall Wayne King

Robin Lee Keich

Detlef Hasse

Michael Panaccio

Richard Strugnell

Robert J Yancey, Jr

James Andrew Leigh

Robert Trygve Good

Mary Jo Baarsch

Lynn Warren-Stewart

Frederick Henry Weber

The present invention provides a method of inducing an immune response againstin an avian species, especially a domesticated avian species such as chicken, turkey, duck, goose and quail, by administering, in ovo, live cells of

[object Object]

The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated byor similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived fromwhich encodes an immunogenic hemolysin peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity againstand related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detectingor similar or otherwise related microorganisms.

Isolated polynucleotide molecules contain a nucleotide sequence that encodes aHtrA, PonA, HypC, LysS, YcfW, ABC1, or Omp100 protein, a substantial portion of the sequences, or a homologous sequence. Related polypeptides, immunogenic compositions and assays are described.

Lawsonia intracellularis proteins, and related methods and materials

The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated byor similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity againstand related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detectingor similar or otherwise related microorganisms.

Therapeutic compositions for treating infection by Lawsonia spp.

The present invention is directed to five novel, low molecular weight proteins from ( ), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against . The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.

Proteins from actinobacillus pleuropneumoniae

Isolated polynucleotide molecules contain a nucleotide sequence that encodes a HtrA, PonA, HypC, LysS, YcfW, ABC1, or Omp100 protein, a substantial portion of the sequences, or a homologous sequence. Related polypeptides, immunogenic compositions and assays are described.

The present invention provides polynucleotide molecules comprising nucleotide sequences encoding plasminogen activating (PauA) proteins from , and substantially homologous polypeptides, peptide fragments, and fusion proteins thereof. The present invention further provides compositions and methods for recombinantly expressing the PauA proteins, substantially homologous polypeptides, peptide fragments and fusion proteins encoded by the polynucleotide molecules of the present invention. The present invention further provides a vaccine for protecting a member of a mammalian species against mastitis, comprising a PauA protein, substantially homologous polypeptide, peptide fragment, fusion protein, or polynucleotide molecule of the present invention.

DNA encoding a plasminogen activating protein

Growing community of inventors

Preston, CT, United States of America

Everett Lee Rosey